triphenyltetrazolium has been researched along with olanzapine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cam, E; Hüdaoglu, O; Kilic, E; Schäbitz, WR; Yildiz, A; Yulug, B | 1 |
| Bakar, M; Ozan, E; Yulug, B | 1 |
| Kilic, E; Yuluğ, B | 1 |
3 other study(ies) available for triphenyltetrazolium and olanzapine
| Article | Year |
|---|---|
Olanzapine attenuates brain damage after focal cerebral ischemia in vivo.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Nerve Degeneration; Neuroprotective Agents; Olanzapine; Tetrazolium Salts; Treatment Outcome | 2006 |
The neuroprotective effect of olanzapine.
Topics: Analysis of Variance; Animals; Benzodiazepines; Brain Infarction; Dose-Response Relationship, Drug; Drug Evaluation; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Olanzapine; Tetrazolium Salts | 2008 |
Olanzapine does not aggrevate ischemic neuronal injury by focal cerebral ischemia: a dose related restriction of the neuroprotective effect?
Topics: Animals; Benzodiazepines; Brain Infarction; Brain Ischemia; Dose-Response Relationship, Drug; Laser-Doppler Flowmetry; Male; Mice; Neurons; Neuroprotective Agents; Olanzapine; Staining and Labeling; Tetrazolium Salts | 2009 |